Fighting against hematological malignancy in China: from unique system to global impact


During recent decades, substantial progress has been made in clinical strategies for treating hematological malignancies. Not only did China benefit from the global progression in the management of acute promyelocytic leukemia, risk-stratification-directed strategies for acute or chronic leukemia and haploidentical hematopoietic stem cell transplantation… (More)
DOI: 10.1007/s11427-015-4926-0

2 Figures and Tables


  • Presentations referencing similar topics